Action of glucose-dependent insulinotropic polypeptide (GIP) in humans
Sources: 1
The breakthrough came at the American Diabetes Association meeting in San Francisco in September 1996
Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market
Kawai Y, Uneda K, Yamada T, Kinguchi S, Kobayashi K, Azushima K, et al
"GLP-1 Moringa Drops" are herbal supplements marketed as natural alternatives to pharmaceutical GLP-1 receptor agonists, suggesting benefits such as: Appetite suppression Metabolism boosting and weight management Blood sugar control However, these specific claims lack strong scientific support from human clinical trials